– Absorbed in a natural and gentle way for the stomach Tolfer is a new iron supplement developed for people with increased iron needs who experience gastrointestinal discomfort from certain traditional iron salts, such as ferrous sulfate. The product is now being launched in Sweden and Finland by Avia Pharma,
STOCKHOLM, Sweden, 9 June 2025
Avia Pharma is expanding its self-care portfolio with the launch of Oralmedic, a fast and effective treatment for mouth ulcers, across the Nordic region…
STOCKHOLM, Sweden, 14 March 2025
Avia Pharma has entered into an exclusive agreement with Nemysis Limited to introduce Tolfer, a next-generation iron supplement containing IHAT (Iron Hydroxide Adipate Tartrate), to the Nordic market…
STOCKHOLM, Sweden, 1 January 2025
Avia Pharma is announcing its official representation in the Nordics of Theramex, a global specialty pharmaceutical company that specializes in women’s health products…
STOCKHOLM, Sweden, 2 February 2024
Avia Pharma Holding AB (“Avia” or the “Company”) has completed the acquisition of Neubourg Skin Care GmbH (“Neubourg”), a leading German dermatology company, specialized in skin, foot and nail care…
STOCKHOLM, Sweden, 2 February 2024
During January, Avia Pharma Holding AB (“Avia” or the “Company”), welcomed Impilo AB as a new owner and partner to the co-founders…
STOCKHOLM, Sweden, 15 June 2023
Avia Pharma has today completed the acquisition of ACO Vitamin D water and will as the new marketing authorisation holder re-launch the pharmaceutical in the Swedish market in Q4 this year…
STOCKHOLM, Sweden, 1 February 2023
Avia Pharma is launching Nyvigan in Swedish pharmacies. Nyvigan (nystatin) is a combination treatment (pessaries + cream) for the treatment of vulvovaginal Candida…
STOCKHOLM, Sweden, 1 August 2022
Avia Pharma has today completed the acquisition of Unimedic’s Vitamin D oil.
STOCKHOLM, Sweden, 29 July 2022
Avia Pharma has today completed the acquisition of Allergika Pharma GmbH. The company has a turnover of close to 15 million EUR and is placed in Wolfratshausen, near Munich…
STOCKHOLM, Sweden, 1 April 2022 Avia Pharma has today completed the acquisition of Decem Pharma. Decem Pharma is a Finish pharmaceutical company with its own brands with strong market positions, such as Magnecit and Otocur. The acquisition of Decem Pharma is Avia Pharma’s first acquisition outside of Sweden and part
Avia Pharma are happy to announce that we have further deepen our relationship with Perrigo to include Dentosal, a much appreciated tooth paste, on the Nordic market.
The pharmaceutical company Avia Pharma has acquired the Swedish pharmaceutical company Pharmaprim, with a product portfolio consisting of drugs in urology, rheumatology and endocrinology.
On December 31, 2019, Avia Pharma acquired the rights to ACO Karbamid and ACO Glycerol from Perrigo.
Following a strong sales increase in the current portfolio, Viiral AS have trusted Avia Pharma to launch Viiral on the Nordic market.
With a strong foot print in women’s health Avia Pharma are trusted to launch Femarelle in Finland.
Following a strong sales increase in the current portfolio, Avia Pharma and Perrigo have deepened the relationship to also include Vectavir®, Vectatone®, Oralmedic® and Predictor®.
Avia Pharma has signed a long-term license agreement with Endoceutics for the Nordic commercial rights to Intrarosa®.
Avia Pharma appoints Mattias Wik as Business Unit Director Oncology/Urology.
Currently there are two Vitamin D drops being sold on the Swedish market. ACO Vitamin D drops does not contain palm oil but the competing product does.